Abstract:Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft-tissue sarcomas that manifest on peripheral nerves, constituting 2% of all sarcomas. They arise both sporadically and in 8% to 13% of individuals with neurofibromatosis type 1 (NF1), where they represent the major cause of morbidity and mortality. While previous genomic analyses of MPNSTs have been conducted on small cohorts, often limited to single samples per patient and lacking comprehensive resolution, the extent of intra-tumor heterogeneity and the contribution of chromosomal instability to MPNST development remain unclear. To address these limitations, we developed a multi-omics integration pipeline and applied it to integrate bulk Next Generation Sequencing (NGS), single-cell RNA sequencing, single-cell DNA sequencing, spatial transcriptomics (ST), and Laser Capture Microsection (LCM) information. 35 tumor samples were collected from 10 patients with MPNST, and for each sample, data were generated using the above five techniques. Overall, we detected copy-number aberrations recurrently found in MPNSTs, including events such as loss of heterozygosity (LOH), whole genome doubling (WGD) and chromosome 7 and 8 amplifications. Subclonal copy number alterations were called by the Battenberg algorithm, followed by SNV clustering using Dirichlet Process-based methods. Applying the pigeonhole principle, we constructed tumor phylogenetic trees. Intriguingly, our findings indicate that for patient 2.3, primary tumor samples PT_1 and PT_2 displayed a close phylogenetic relationship, while local recurrences LR_2 and LR_3 represent a different branch of the phylogenetic tree. Following stringent quality control and cell type annotation, we leveraged normal cells identified within the snRNA data as controls to infer copy number changes in tumor cells through inferCNV. Notably, in patient 2.16, we identified significant copy number gains on chromosomes 5, 7, 8, and 15. Comparing the inferred copy number changes derived from snRNA with those obtained through Battenberg copy number profiles showed a remarkable congruence, thereby reinforcing the robustness of our results. To reveal communication networks among tumor microenvironment (TME) cells, we used iTalk to visualize ligand-receptor interactions between distinct cell types. For Patient 2.3, macrophages emerged as key players, releasing cytokines such as IL-16 and IL-18, which exerted their influence on receptors in tumor cells. Additionally, T cells engaged in checkpoint factors, including TNFSF4 and CD28, interacting with receptors on tumor cells, such as TRAF2 and LGALS9. Our research revealed that MPNSTs are primarily driven by chromosomal instability and intra-tumor heterogeneity is shaped by TME interactions. We enhanced our understanding of the tumors' evolutionary histories and intra-tumor heterogeneity down to single-cell resolution. By shedding light on the genomic landscape of MPNSTs, we aspire to make profound contributions to the field of sarcoma research, ultimately improving patient outcomes. Citation Format: Yixiao Cheng, Haixi Yan, Maxime Tarabichi, Zhihui Zhang, Chunxu Gao, Tom Lesluyes, Adrienne Flanagan, Peter Van Loo. Profiling intra-tumor heterogeneity and chromosomal instability in malignant peripheral nerve sheath tumors [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr B002.

Aberrations of TBX2-CHK2-p53 Signaling Pathway and Its Role in Malignant Peripheral Nerve Sheath Tumors

Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy.

Abstract B002: Profiling intra-tumor heterogeneity and chromosomal instability in malignant peripheral nerve sheath tumors

Comprehensive Profiling of MDM2/TP53 Genomic Aberration in Chinese Patients with Diverse Malignancies.

[Expression and its clinical significance of cell-cycle dependent kinase 1 in malignant peripheral nerve sheath tumors]

From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor

Abstract 5671: Profiling intra-tumor heterogeneity and chromosomal instability in malignant peripheral nerve sheath tumors

Retraction Note: Genomic Amplification and High Expression of EGFR Are Key Targetable Oncogenic Events in Malignant Peripheral Nerve Sheath Tumor.

[Targeted Therapy for Malignant Peripheral Nerve Sheath Tumor: Translational Research and Clinical Application].

Prognostic Roles for Fibroblast Growth Factor Receptor Family Members in Malignant Peripheral Nerve Sheath Tumor

Genomic And Molecular Characterization Of Malignant Peripheral Nerve Sheath Tumor Identifies The Igf1r Pathway As A Primary Target For Treatment (Publication With Expression Of Concern. See Vol. 25, Pg. 3195, 2019)

Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis

Qlti-20. Bridging The Gap: Understanding The Current Treatment Responses To Enhance The Standard Of Care And Outcomes For Malignant Peripheral Nerve Sheath Tumors

TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas

EZH2-miR-30d-KPNB1 Pathway Regulates Malignant Peripheral Nerve Sheath Tumour Cell Survival and Tumourigenesis.

[Analysis of clinical features, treatment methods, and prognostic influence factors in patients with malignant peripheral nerve sheath tumor]

TYK2 Promotes Malignant Peripheral Nerve Sheath Tumor Progression Through Inhibition of Cell Death.

Retroperitoeal malignant peripheral nerve sheath tumors: a clinicopathologic study of 13 cases

Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents

Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma